Status | Study |
Recruiting |
Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency Condition: Aggressive Non-Hodgkin Lymphoma Anaplastic Large Cell Lymphoma Date: 2013-02-06 Interventions: Dietary Supplement: Cholecalciferol |
Recruiting |
Study Name: CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Condition: ALK-negative Anaplastic Large Cell Lymphoma Peripherial T Cell Lymphoma,Not Otherwise Specif Date: 2012-12-04 Interventions: Drug: Cyclophosphamide 750mg/m2 |
Completed |
Study Name: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma Condition: Peripheral T-cell Lymphoma (Not Otherwise Specified) Angioimmunoblastic T-cell Lymphoma Date: 2009-05-11 Interventions: Drug: panobinostat and bortezomib oral panobinostat 30 mg 3 times per week AND intravenous bortezomib 1. |
Terminated |
Study Name: Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma Condition: Lymphoma Date: 2008-12-16 Interventions: Drug: Vorinostat Dose of 200 m |
Completed |
Study Name: SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma Condition: Lymphoma Date: 2008-11-06 Interventions: Drug: Zolinza (vorinostat) Up |
Completed |
Study Name: Study of MLN8237 in Participants With Advanced Hematological Malignancies Condition: B-cell Follicular Lymphoma B-cell Marginal Zone Lymphoma D Date: 2008-06-11 Interventions: Drug: Alisertib Alisertib (MLN8237) PIC or ECT Other |
Terminated |
Study Name: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma Condition: 714leukemia Lymphoma Date: 2008-05-02 Interventions: Drug: Bortezomib |
Withdrawn |
Study Name: High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma Condition: Lymphoma Small Intestine Cancer Date: 2008-04-30 Interventions: Drug: carmustine Drug: cyclophosphamide |